Formulation and physicochemical characterization of poly(ε-caprolactone) nanoparticles loaded with ftorafur and diclofenac sodium

Colloids and Surfaces B: Biointerfaces

Volumn 75, Issue 1, 2010, Pages 204-208

  Arias, José L ^a   López Viota, Margarita ^a   Sáez Fernández, Eva ^a   Ruiz, M Adolfina ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

Biodegradable polymers; Controlled release; Diclofenac sodium; Drug delivery systems; Ftorafur; Poly( caprolactone)

Indexed keywords

CAPROLACTONE; CONTROLLED RELEASE; DICLOFENAC SODIUM; DRUG DELIVERY SYSTEM; FTORAFUR;

ADSORPTION; BIODEGRADABLE POLYMERS; DRUG DOSAGE; DRUG INTERACTIONS; FUNCTIONAL POLYMERS; NANOPARTICLES; SODIUM;

CONTROLLED DRUG DELIVERY;

DICLOFENAC; NANOPARTICLE; POLYCAPROLACTONE; TEGAFUR;

ARTICLE; DRUG ADSORPTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL;

ADSORPTION; CHEMISTRY, PHARMACEUTICAL; DICLOFENAC; ELECTROPHORESIS; NANOPARTICLES; PARTICLE SIZE; PHYSICOCHEMICAL PHENOMENA; POLYESTERS; TEGAFUR;

EID: 70449670601     PISSN: 09277765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2009.08.032     Document Type: Article

References (25)

1. Carson J., Notis W.M., and Orris E.S. N. Engl. J. Med. 323 (1989) 135
2. Cooke J.W.B., Bright R., Coleman M.J., and Jenkins K.P. Org. Process Res. Dev. 5 (2001) 383
3. Zhang N., Yin Y., Xu S.J., and Chen W.S. Molecules 13 (2008) 1551
4. Davies N.M. J. Pharm. Pharm. Sci. 2 (1999) 5
5. Moghimi S.M., Hunter A.C., and Murray J.C. Pharmacol. Rev. 53 (2001) 283
6. Couvreur P., and Vauthier C. Pharm. Res. 23 (2006) 1417
7. Farokhzad O.C., and Langer R. ACS Nano 3 (2009) 16
8. Pérez M.H., Zinutti C., Lamprecht A., Ubrich N., Astier A., Hoffman M., Bodmeier R., and Maincent P. J. Control. Rel. 65 (2000) 429
9. Sinha V.R., Bansal K., Kaushik R., Kumria R., and Trehan A. Int. J. Pharm. 278 (2004) 1
10. Vauthier C., Dubernet C., Fattal E., Pinto-Alphandary H., and Couvreur P. Adv. Drug Deliv. Rev. 55 (2003) 519
11. Brigger I., Morizet J., Laudani L., Aubert G., Appel M., Velasco V., Terrier-Lacombe M.J., Desmaële D., d'Angelo J., Couvreur P., and Vassal G. J. Control. Rel. 100 (2004) 29
12. N.B. Leodinov, US Patent 6538001, 2003.
13. Palomo M.E., Ballesteros M.P., and Frutos P. J. Pharm. Biomed. Anal. 21 (1999) 83
14. Ameller T., Marsaud V., Legrand P., Gref R., and Renoir J.M. Eur. J. Pharm. Sci. 21 (2004) 361
15. Arias J.L., Gallardo V., Ruiz M.A., and Delgado A.V. Int. J. Pharm. 337 (2007) 282
16. Llovet M.I., Egea M.A., Valero J., Alsina M.A., García M.L., and Chauvet A. Drug Dev. Ind. Pharm. 21 (1995) 1761
17. Stolnik S., Illum L., and Davis S.S. Adv. Drug Deliv. Rev. 16 (1995) 195
18. McCarron P.A., Woolfson A.D., and Keating S.M. J. Pharm. Pharmacol. 52 (2000) 1451
19. Soppimath K.S., Aminabhavi T.M., Kulkarni A.R., and Rudzinski W.E. J. Control. Rel. 70 (2001) 1
20. Ferranti V., Marchais H., Chabenat C., Orecchioni A.M., and Lafont O. Int. J. Pharm. 193 (1999) 107
21. Ha J.H., Kim S.H., Han S.Y., Sung Y.K., Lee Y.M., Kang I.K., and Cho C.S. J. Control. Rel. 49 (1997) 253
22. Lemmouchi Y., Schacht E., and Lootens C. J. Control. Rel. 55 (1998) 79
23. Blanco M.D., Bernardo M.V., Sastre R.L., Olmo R., Muñiz E., and Teijón J.M. Eur. J. Pharm. Biopharm. 55 (2003) 229
24. Gibaud S., Al Awwadi N.J., Ducki C., and Astier A. Int. J. Pharm. 269 (2004) 491
25. Wang X., Wang Y., Wei K., Zhao N., Zhang S., and Chen J. J. Mater. Process Technol. 209 (2009) 348